EQUITY (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 24, 2026 |
Feb. 10, 2026 |
Nov. 21, 2025 |
Oct. 27, 2025 |
Mar. 21, 2025 |
Feb. 28, 2025 |
Jan. 25, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Subsidiary, Sale of Stock [Line Items] | |||||||||||
| Reverse stock split | 1-for-10 reverse stock split | ||||||||||
| Statutory common reserve fund, description | The Company’s PRC subsidiaries are required each year to transfer at least 10% of the profit after tax as reported under the PRC statutory financial statements to the Statutory Reserve until the balance reaches 50% of the registered share capital. This reserve can be used to make up for any loss incurred or to increase share capital. Except for the reduction in losses incurred, any other application should not result in this reserve balance falling below 25% of the registered capital. As of March 31, 2026, the Company’s statutory provident fund stood at $26.67 million. | ||||||||||
| Stockholders equity description | On January 26, 2026, March 5, 2026, March 19, 2026 and March 28, 2026, respectively, the Company entered into equity financing agreements (individually the “Private Placement Agreement”; collectively the “Private Placement Agreements”), with four individual investors (individually the “Private Placement Purchaser”; collectively “Private Placement Purchasers”), pursuant to which the Company agreed to issue new shares of common stock to such investors that in aggregate accounted for approximately 18% of the total shares issued and outstanding of the Company as of December 31, 2025. The purchase price per share under the Private Placement Agreement dated January 26, 2026, was set at 90% of the average closing price of the Company’s common stock for the five trading days prior to the date of such agreement, while the purchase prices under the Private Placement Agreements executed in March 2026 were set at 85% of, or 15% off, the closing price of the Company’s common stock on the trading day immediately preceding the respective agreement dates, as quoted on the Nasdaq Stock Market. | ||||||||||
| Proceeds from sale of private placement units | $ 280,172 | ||||||||||
| One Individual [Member] | Private Placement [Member] | |||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||
| Number of shares issued | 75,000 | 69,000 | |||||||||
| Share price | $ 3.57 | $ 3.57 | |||||||||
| Proceeds from sale of private placement units | $ 267,750 | $ 246,330 | |||||||||
| Two Thousand Nineteen Omnibus Incentive Plan [Member] | |||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||
| Restricted shares issued for service, shares | 265,000 | 295,000 | |||||||||
| Fair value of restricted shares issued on grant date | $ 196,100 | $ 194,700 | |||||||||
| Two Thousand Nineteen Omnibus Incentive Plan [Member] | Post Reverse Share Split [Member] | |||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||
| Restricted shares issued for service, shares | 26,500 | 29,500 | |||||||||
| Two Thousand Twenty Five Omnibus Incentive Plan [Member] | |||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||
| Restricted shares issued for service, shares | 186,000 | ||||||||||
| Fair value of restricted shares issued on grant date | $ 734,700 | ||||||||||
| Acquisition Agreements [Member] | |||||||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||||||
| Shares issued | 2,059,694 | ||||||||||
| Shares issued reverse stock splits | 205,969 | ||||||||||
| Shares issued price per share | $ 1.50 | ||||||||||